Global PharmaPartners, Inc. (GPP) represents international and domestic pharmaceutical R&D partners in the licensing of their product portfolio to GPP Clients in the USA, Canadian, and around the globe. GPP supports our partners with excellent pipeline selection, portfolio management, sales and marketing analysis, contract negotiations, and mergers and acquisitions. GPP represents a diverse group of R&D partners covering retail, hospital, specialty pharmaceutical, specialty pharma, 505(b)(2) or hybrids, branded/innovative, and biological Rx product portfolios.
Value Creation with foreign dossiers and converting to FDA standards,
introducing foreign pharmaceutical companies to America's most excellent and successful marketing and commercial partners.
superior value for pharmaceutical deal structuring as compared to our peers.
Deals/Licensing of drug developments from conception stages to drug procurement and brokering.
Regulatory - Filing with FDA, Health Canada, MHRA, EMA, ANVISA, GCC, WHO, and many other regulatory bodies: NDA's (New Drug Applications), BLA's (Biologics License Applications), ANDA's (generic) and 505(b) (2) (or hybrids as known in EU) pharmaceutical product files.
Litigation representation for Paragraph Four opportunities.
Your total solutions provider...
Vice President BD
MSc - Microbiology
MBA -Pharmaceutical Mgmt
Kuntal has around 22 plus years of experience in RA, Quality, Portfolio, and BD topics.
He has worked in various senior leadership roles at Dr. Reddys, Sandoz, Woerwag, Apotex, Aurobindo, and Berlin Chemie.
Currently, from Nov 2020. Kuntal is a freelancer BD Consultant for GPP, assisting companies globally with their portfolio and BD strategy to grow their global business and helping them with market access, Licensing needs, Business growth, and M&A activities. He is also assisting senior and board-level introductions with Pharma bosses globally